A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of TYRA-300 in Children with Achondroplasia with Open Growth Plates: BEACH301

The purpose of this study is to evaluate the safety, tolerability, and identify potentially effective dose(s) of TYRA-300 in children with achondroplasia with open growth plates.

Study ID: 5009
NCT Number: NCT06842355
Principal Investigator: Daniel Hoernschemeyer, MD
Department: Orthopaedic Surgery
Eligibility: Both men and women 3 years old to 10 years old. Does not accept healthy volunteers.

For questions about this study, please contact:

ClinicalTrialsInterest@health.missouri.edu
(573) 882-7026